Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 2/20 | 0.48 |
| ▸ | FAAH | O00519 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 4/20 | 0.38 |
| ▸ | TLR9 | Q9NR96 | 2/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 5/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | STAT3 | P40763 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | TRIP13 | Q15645 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | PPARD | Q03181 | 1/20 | 0.33 |
| ▸ | PPARA | Q07869 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL237914 | 0.89 | GAA (0.44) | MGLLFAAHSMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL24741191 | 0.83 | MGLL (0.54) | MGLLFAAHALDH1A1LMNAGAA | |
| SCHEMBL12317338 | 0.81 | TRIM24 (0.42) | SMN1; SMN2ALDH1A1GAATLR9PKM | |
| SCHEMBL4894350 | 0.80 | MEN1 (0.54) | MGLLSMN1; SMN2ALDH1A1LMNAMEN1 | |
| SCHEMBL2983688 | 0.80 | GAA (0.57) | MGLLSMN1; SMN2ALDH1A1LMNAGAA | |
| SCHEMBL4443303 | 0.80 | MGLL (0.56) | MGLLFAAHALDH1A1LMNAPKM | |
| SCHEMBL225820 | 0.79 | GAA (0.58) | MGLLALDH1A1GAATLR9PKM | |
| SCHEMBL24741188 | 0.77 | ALDH1A1 (0.38) | SMN1; SMN2ALDH1A1LMNAGAATLR9 | |
| SCHEMBL22728447 | 0.76 | BCHE (0.47) | SMN1; SMN2ALDH1A1LMNAKCNH2GAA | |
| SCHEMBL12268781 | 0.75 | ADAM17 (0.50) | SMN1; SMN2ALDH1A1GAATLR9MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230365730-A1 | HIGH TEMPERATURE BENZOXAZINE RESINS, METHODS, AND USES THEREOF | KANEKA CORPORATION (JP) | 2023-11-16 | — | — | US | disclosed |
| US-20230365730-A1 | HIGH TEMPERATURE BENZOXAZINE RESINS, METHODS, AND USES THEREOF | KANEKA CORPORATION (JP) | 2023-11-16 | — | — | US | disclosed |
| EP-0800551-B1 | SULFUR-VULCANIZED RUBBER COMPOSITIONS COMPRISING SUBSTITUTED SUCCINIMIDE COMPOUNDS | AKZO NOBEL NV (NL) | 2001-06-13 | — | — | EP | disclosed |
| US-5844049-A | Sulfur-vulcanized rubber compositions comprising substituted succinimide compounds | AKZO NOBEL NV (NL) | 1998-12-01 | — | — | US | disclosed |
| EP-0800551-A1 | SULFUR-VULCANIZED RUBBER COMPOSITIONS COMPRISING SUBSTITUTED SUCCINIMIDE COMPOUNDS | Akzo Nobel N.V. (NL) | 1997-10-15 | — | — | EP | disclosed |
| WO-1996020246-A1 | SULFUR-VULCANIZED RUBBER COMPOSITIONS COMPRISING SUBSTITUTED SUCCINIMIDE COMPOUNDS | AKZO NOBEL N.V. (NL) | 1996-07-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230365730-A1 | HIGH TEMPERATURE BENZOXAZINE RESINS, METHODS, AND USES THEREOF | KDM5C, DHX15, KDM5A | MGLL 4346/4885FAAH 756/4885SMN1; SMN2 2769/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.